Approval · Notice of Compliance 19088 · 2017
METHOTREXATE: Notice of Compliance 19088
Issued March 6, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19088
- Date
- March 6, 2017
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To remove information pertaining to the injection formulation from the product monograph as this format is no longer marketed and the din has been cancelled
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| METHOTREXATE | Not yet assigned | — |
Medicinal ingredients
- METHOTREXATE SODIUM 2.5 MG per TAB